SecBot SecBot
SECBOTREPLAY Home › Report › GENB

GENB · A cluster of insider transactions at Generate Biomedicines (GENB) over…

Generate Biomedicines, Inc. · CLUSTER filed Mar 2, 2026 at 17:54 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Mar 2, 2026 at 17:54 ET

A cluster of insider transactions at Generate Biomedicines (GENB) over the past week includes two open-market purchases totaling $32,000 by executives Mendillo Jane L and Silvers Jason, alongside multiple non-cash derivative conversions by insiders including CEO Michael Nally and others. The purchases are small in absolute value and represent minimal economic activity relative to the company's market cap.

  • Two open-market purchases occurred: Mendillo Jane L bought 1,500 shares ($24,000) and Silvers Jason (President & CFO) bought 500 shares ($8,000).
  • Multiple non-cash derivative conversions totaling over 26 million shares were executed at $0 value, including by CEO Michael Nally and Stephane Bancel.
  • Total open-market buying: $32,000 over 7 days, consistent with recent 30-day activity.
  • No open-market selling occurred in the cluster.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access